未找到相关数据
The cost-effectiveness of pioglitazone compared with rosiglitazone: An economic evaluation projecting results from a clinical study into the future using a valid and reliable economic model from a third party payer perspective in the USA
被引：0
作者：
Minshall, M.
[1
]
St. Charles, M.
[1
]
Pandya, B.
[2
]
Baran, R. W.
[2
]
机构：
[1] IMS Hlth, Noblesville, IN USA
[2] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A259 / A259
页数：1
相关论文